Using high-flow nasal cannulas to prevent oxygen drops during sedated GI endoscopy in critically ill patients
Official title: Effect of High Flow Nasal Cannula Oxygenation on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients: A Multicentre Randomised Controlled Trial
Run by Zhejiang University · NCT07252102 · Data updated 2026-11-12
This trial will test whether high-flow nasal cannulas during sedated gastrointestinal endoscopy can prevent low oxygen levels in critically ill (ASA 3–4) adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 450 (estimated) |
| Sponsor | Zhejiang University Academic / other |
| Locations | 3 sites (Shenzhen, Guangdong and 2 other locations) |
| Status | Recruiting |
| Started | November 20, 2025 |
| Main results expected | December 28, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | January 20, 2026 |
| Trial ID | NCT07252102 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 having elective gastroenteroscopy with ASA grade 3–4, BMI 18–28 kg/m2, procedure time expected ≤60 minutes, and able to give informed consent are ideal candidates.
✕Probably not a fit
Patients who cannot use HFNC (nasal obstruction, recent nasal surgery/trauma, active nasal bleeding), those with COPD, acute respiratory infection or asthma attack, difficult airway, acute GI bleeding with shock, gastric outlet obstruction with retained contents, allergy to sedatives like propofol, or severe cognitive impairment are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Critically ill adults (ASA grade 3–4) scheduled for elective gastrointestinal endoscopy will be assigned to receive either high-flow nasal catheter oxygen or standard nasal catheter oxygen during sedation. The study compares the incidence of hypoxia, severe hypoxia, and subclinical respiratory depression using predefined SpO2 thresholds and durations. Investigators will also record respiratory- and sedation-related adverse events and procedure-related complications. The trial is conducted at multiple tertiary hospitals in China and focuses on procedures expected to last 60 minutes or less.
Why it matters
Potential benefit: If successful, HFNC could reduce episodes of low oxygen and related complications during sedated GI procedures in high-risk patients.
How similar studies have gone: Previous studies have shown HFNC reduces hypoxia during sedated endoscopy in ASA 1–2 and obese patients, but its benefit in ASA 3–4 critical patients remains to be confirmed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18≤ age ≤80, gender is not limited; 2. Patients undergoing elective gastroenteroscopy or treatment; 3. ASA grade Ⅲ\~Ⅳ; 4. 18 kg/m2≤BMI≤28kg/m2; 5. The operation time of gastroenteroscopy is expected to be no more than 60min; 6. Clearly understand, voluntarily participate in the study, and have informed consent from myself or my family members. Exclusion Criteria: 1. Patients with nasal congestion, nasal bleeding, recent nasal trauma, recent nasal surgery, increased intracranial pressure and skull fracture, etc., who can not perform high-flow nasal catheter oxygen; 2. acute respiratory infections and asthma attacks; 3. Patients diagnosed with COPD; 4. Clear difficult airway; 5. Acute upper gastrointestinal bleeding with shock; 6. Gastrointestinal obstruction with gastric content retention; 7. Allergic to sedatives such as propofol; 8. Persons with no capacity for civil conduct such as cognitive dysfunction.
Where it's running
-
Shenzhen Hospital of Southern Medical University
Shenzhen, Guangdong, China Recruiting -
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
Shenzhen, Guangdong, China Recruiting -
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Diansan SU, Cheif of Anesthesiology Department, PhD
- Email: 184872238@qq.com
- Phone: +8618616514088
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using spleen size to help detect gastroesophageal varices in compensated cirrhosis
This study tests whether ultrasound measurements of spleen size can help identify esophageal varices in adults with compensated cirrhosis, compared with the standard endoscopy test.
-
Laparoscopic liver and spleen removal for small liver cancer in people with cirrhosis and enlarged spleen
This study tests whether removing part of the liver and the spleen during one operation helps people with small liver cancers and hypersplenism by improving liver function and immune balance.
-
Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS
A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.
-
Foscenvivint in HIV/HCV co-infected adults with liver cirrhosis and hemophilia
This study tests whether foscenvivint can help people with liver cirrhosis due to HIV/HCV co-infection who also have hemophilia.
-
Austrian PBC Registry
This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.
-
Reference framework for outcomes after machine-preserved liver transplantation in Europe
This study tests how liver transplants that use machine perfusion perform in real-world practice, to see how different perfusion methods relate to outcomes for adults in Europe.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.